Annexon Stock

Annexon EPS

The Earnings per Share (EPS) of Annexon (ANNX) as of Aug 3, 2026 is -1.33 USD. In the previous year, Earnings per Share (EPS) was -0.93 USD — a change of 42.53% (lower).

EPS

-1.33USD

YoY

42.53%

Last updated:

Earnings per Share (EPS) of Annexon is 2026 -1.33 USD. Earnings per Share (EPS) of Annexon was 2025 -0.93 USD. It decreases by 42.53% lower compared to the previous year.
Access this data via the Eulerpool API

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Earnings per Share (EPS) of Annexon is -1.33 USD in 2026.

Earnings per Share (EPS) of Annexon changed from -0.93 USD to -1.33 USD, representing a 42.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Annexon since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Annexon

All Key Metrics — Annexon